AU2020900887A0 - Peptides and their use in diagnosis - Google Patents

Peptides and their use in diagnosis

Info

Publication number
AU2020900887A0
AU2020900887A0 AU2020900887A AU2020900887A AU2020900887A0 AU 2020900887 A0 AU2020900887 A0 AU 2020900887A0 AU 2020900887 A AU2020900887 A AU 2020900887A AU 2020900887 A AU2020900887 A AU 2020900887A AU 2020900887 A0 AU2020900887 A0 AU 2020900887A0
Authority
AU
Australia
Prior art keywords
peptides
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900887A
Inventor
Bror Samuel LUNDIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotome Pty Ltd
Original Assignee
Biotome Pty Ltd
Filing date
Publication date
Application filed by Biotome Pty Ltd filed Critical Biotome Pty Ltd
Publication of AU2020900887A0 publication Critical patent/AU2020900887A0/en
Abandoned legal-status Critical Current

Links

AU2020900887A 2020-03-23 Peptides and their use in diagnosis Abandoned AU2020900887A0 (en)

Publications (1)

Publication Number Publication Date
AU2020900887A0 true AU2020900887A0 (en) 2020-04-02

Family

ID=

Similar Documents

Publication Publication Date Title
IL291484A (en) Multi-targeting effector cells and use thereof
EP4119162A4 (en) Pvrig binding protein and its medical uses
EP3749313A4 (en) Alpha polyglutamated antifolates and uses thereof
EP3800193A4 (en) Peptide having skin whitening activity and use thereof
EP3964531A4 (en) Protein molecule and use thereof
EP3749315A4 (en) Alpha polyglutamated raltitrexed and uses thereof
EP3587440A4 (en) Human pd-l1 high-protein-affinity peptide and use thereof
EP3741748A4 (en) Compound and use thereof in medicine
EP3999544A4 (en) Polypeptide complex for conjugation and use thereof
EP3938051A4 (en) Peptidomimetic macrocycles and uses thereof
EP3882263A4 (en) Glucagon-derived peptide and use thereof
EP4190802A4 (en) Cell-penetrating peptide and use thereof
EP3712268A4 (en) Transformed human cell and use thereof
EP3955938A4 (en) Unraveling receptor-metabolite interactions in the human microbiome
AU2020234373A1 (en) Novel peptide and use thereof
AU2021900617A0 (en) Peptides and their use in diagnosis
AU2021900616A0 (en) Peptides and their use in diagnosis
AU2020900885A0 (en) Peptides and their use in diagnosis
AU2020900887A0 (en) Peptides and their use in diagnosis
EP3800194A4 (en) Peptide having skin whitening activity and use thereof
AU2023902106A0 (en) Peptides and Their Use in Diagnosis
AU2023902104A0 (en) Peptides and Their Use in Diagnosis
AU2022900536A0 (en) Peptides and their use in diagnosis
AU2022900537A0 (en) Peptides and their use in diagnosis
EP4032611A4 (en) Composite material and use thereof in desulfurization